Dr Marc Laniado made a choice to be more mindful of his own health - here's what he discovered, from 'exercise snacking' to ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...

Shares rebound from Monday’s $90b wipeout; oil back to $US90 after earlier surge toward $120; Fortescue completes Alta buy; Air New Zealand axes guidance over conflict. Follow live.

Astellas Pharma has awarded its healthcare provider (HCP) and direct-to-consumer (DTC) business to CMI Media Group, Compas and WPP Media, the drugmaker confirmed Monday afternoon. According to ...

But here's why you likely won't be seeing it in your doctor's office anytime soon.

LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 – – Reduced secured and convertible debt by 90% from $480 million to $38.8 million over 2024-2025 – – $172.1 ...

Clarity Pharmaceuticals Ltd (ASX: CU6) shares are having a strong session on Tuesday. At the time of writing, the ASX 200 share is up 7% to $3.52 after the company released a clinical trial update.

New research suggests that a vegetarian diet can help lower the risk of cancer, but not in all cases. We spoke to experts to ...

Incidental detection has increased with ubiquitous CT/MRI, inflating early-stage ‘small renal mass’ diagnoses and complicating interpretation of a ~5% rise in <50-year incidence. Obesity, hypertension ...

Shares to rebound from Monday’s $90b wipeout; oil back to $US90 after earlier surge toward $120; Fortescue completes Alta buy; Air New Zealand axes guidance over conflict. Follow live.

Proteoforms, the diverse molecular variants of proteins, are key to understanding cellular functions, disease mechanisms, and ...